AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 156 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $645,000 | +4.0% | 19,314 | 0.0% | 0.03% | 0.0% |
| Q2 2014 | $620,000 | -30.5% | 19,314 | 0.0% | 0.03% | -32.6% |
| Q1 2014 | $892,000 | -24.9% | 19,314 | +15.5% | 0.05% | -24.6% |
| Q4 2013 | $1,187,000 | -17.2% | 16,724 | 0.0% | 0.06% | -21.8% |
| Q3 2013 | $1,434,000 | -12.2% | 16,724 | -35.2% | 0.08% | -15.2% |
| Q2 2013 | $1,634,000 | – | 25,804 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |